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Abstract Endogenous and recombinant cruzipain, the major
cysteine proteinase from the protozoan parasite Trypanosoma
cruzi, exhibit differences in the protein and circular dichroism
spectra probably attributed to the absence of the C-terminal
domain in the recombinant enzyme. Substrate hydrolysis of both
molecules at 25‡C and neutral pH obeyed Michaelis-Menten
kinetics whereas significant substrate inhibition was observed
above neutral pH. The results suggest that substrate inhibition of
cruzipain is pH-dependent, and that the C-terminal domain does
not play an essential role in this process.
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1. Introduction
Cysteine proteinases belonging to the papain superfamily
are present in all groups of eukaryotes, except fungi [1].
Most of the proteinase activity detected in trypanosomatids
(Trypanosoma cruzi, T. brucei) and various Leishmania spp.
has been characterized as type I cysteine proteinases which are
cathepsin L-like enzymes with an unusual C-terminal exten-
sion [2,3]. A C-terminal domain [4] is also found in plants
such as tomato [5] and rice [6]. The length of the C-terminal
extension ranged from 100 to 130 amino acids [2,7^9], and the
sequence between the catalytic domain and the C-terminal
domain, containing clusters of Thr, Pro and Ser, is susceptible
to proteolytic cleavage [2,4,5]. The function of the C-terminal
domain is unknown. It has been proposed to be involved in
the evasion of the immune response of the host [10] and en-
hancement of the catalytic activity [11]. Other hypotheses on
its role in targeting of the enzyme to the lysosomes or protein
folding have been excluded [3,8].
Cruzipain (cruzain, gp 57/51) is the major protease of the
protozoan parasite T. cruzi [12]. The cruzipain gene encodes a
protein which contains a prepro region, a catalytic domain
and a C-terminal domain [7,8]. Recombinant cruzipain has
been expressed in Escherichia coli [8]. After complete proteo-
lytic processing only the catalytic domain of the enzyme was
recovered [13]. Using small synthetic substrates, cruzipain
showed temperature-dependent substrate inhibition which
was suggested to be due to its C-terminal domain [14].
In order to de¢ne if the C-terminal domain plays a major
role in substrate inhibition or other catalytic properties of the
protease, studies were carried out on endogenous and re-
combinant cruzipain molecules, containing or lacking the C-
terminal domain. Circular dichroism (CD) spectra of both
proteins were scanned for comparison. The complete pH pro-
¢le for the second order rate constant kcat/Km for the hydrol-
ysis of Z-Phe-Arg-MCA and Z-Arg-Arg-MCA by cruzipain
has been determined.
2. Materials and methods
Dithioerythritol and EDTA were purchased from Sigma (USA).
HEPES, glycine and MCA were from Serva (Germany). Z-Phe-Arg-
MCA and Z-Arg-Arg-MCA were obtained from Bachem (Switzer-
land). E-64 was provided by the Peptide Research Institute (Japan).
Dimethyl sulfoxide was from Merck (Germany). All other chemicals
were of analytical grade. Stock solutions of substrates and inhibitor
were prepared in dimethyl sulfoxide.
2.1. Enzyme puri¢cation
Cruzipain was isolated from T. cruzi epimastigotes, TulahueŁn
strain, Tul 2 stock [15]. A truncated variant of recombinant cruzipain
lacking the C-terminal domain was expressed in E. coli as a fusion
protein as described [13]. The fully processed recombinant enzyme
was further puri¢ed on a Superdex 75 HR column (Pharmacia, Swe-
den) equilibrated with 100 mM phosphate bu¡er, 1 mM EDTA,
300 mM NaCl, pH 7.0. The enzyme activity was measured using Z-
Phe-Arg-MCA substrate. Enzymatically active fractions were pooled,
concentrated and stored at 320‡C prior to use. The active concen-
tration of the enzymes was determined by active site titration with E-
64 [16].
2.2. Protein concentration
Protein concentration was determined by absorbance measurements
at 280 nm in a Perkin Elmer UV/VIS Spectrometer Lambda 18
(USA). Molar absorption coe⁄cient values of 58 285 M31 cm31 for
endogenous cruzipain and 54 930 M31 cm31 for recombinant cruzi-
pain were calculated from amino acid sequences [17].
2.3. Circular dichroism
CD spectra were recorded using an AVIV 62 DS spectropolarimeter
at 25‡C. A cell with 0.1 cm path length was used for far-UV (190^250
nm) measurements and a 1 cm path length cell for the near-UV region
(250^340 nm). Data were collected every 0.5 nm for the far-UV and
every 1.0 nm for the near-UV regions, with a time constant of 2 s and
a spectral bandwidth of 0.5 nm. Each spectrum was the average of
three repetitive scans corrected for cell and solvent contributions. The
CD spectra of endogenous and recombinant cruzipain were scanned
under native conditions at pH 7.0. The enzyme concentration was
7 WM. In the far-UV CD the results are reported in terms of mean
residue ellipticity [a]MRW de¢ned as [a]MRW = [a]UMRW/(10UcUl)
where a is the ellipticity in millidegrees, c is the concentration in
mg/ml and l is the light path length in cm. MRW is the mean residue
weight, 105 for endogenous cruzipain and 110 for recombinant cruzi-
pain. In the near-UV CD the results are reported in molarity. The
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secondary structure composition was estimated by the CONTIN algo-
rithm [18].
2.4. Dependence of the rate of hydrolysis on substrate concentration
Enzyme samples were activated with dithioerythritol (2 mM ¢nal
concentration) for 5 min at 25‡C. 10 Wl of the activated sample (52 nM
¢nal concentration) was added to 390 Wl of Z-Phe-Arg-MCA (0.1^200
WM) dissolved in 100 mM phosphate bu¡er (Na2HPO4/KH2PO4), pH
7.0 or in 50 mM glycine bu¡er, pH 9.0, both containing 1 mM EDTA
and 100 mM NaCl. The progress of the reaction was followed con-
tinuously at 25‡C for 20 s using Perkin Elmer Luminescence Spec-
trometer LS 50 (USA) with excitation and emission wavelengths of
370 and 460 nm, respectively. Enzymes were shown to be stable dur-
ing the measurements. In all experiments, dimethyl sulfoxide content
was adjusted to 3% and substrate consumption was limited to less
than 5%.
2.5. pH dependence of kcat /Km
pH dependence studies were carried out in bu¡ers prepared by
mixing the following solutions in the appropriate ratio: 100 mM citric
acid and 200 mM Na2HPO4W2H2O (pH 2.2^8.0), 50 mM
Na2B4O7W10H2O and 100 mM HCl (pH 8.0^9.0), 50 mM
Na2B4O7W10H2O and 100 mM NaOH (pH 9.0^10.5). All bu¡ers con-
tained 1 mM EDTA and 100 mM NaCl. 10 Wl of activated cruzipain
(0.1 WM) was added to 490 Wl of Z-Phe-Arg-MCA (0.1^1 WM) or Z-
Arg-Arg-MCA (0.5^3 WM) in bu¡er solutions from pH 2.7 to 10.2 at
25‡C. Due to the low signal/noise ratio for the measurements per-
formed in the presence of Z-Arg-Arg-MCA substrate below pH 4.5,
20 Wl of activated cruzipain (4.8 WM) was added to 480 Wl of substrate.
Enzyme activity was measured as described above. The £uorimeter
was calibrated with 0.25 WM MCA in the same bu¡er solutions.
3. Results and discussion
3.1. Protein spectra
The protein spectrum of endogenous cruzipain exhibits a
pro¢le with a maximum at 280 nm whereas an unusual
12 nm red shift of its maximum was observed on recombinant
cruzipain (Fig. 1). The primary structure of cruzipain [7,8]
indicates that the entire aromatic environment contains eight
tryptophans, eight phenylalanines and nine tyrosine residues
whereas the catalytic domain of the molecule, represented by
the recombinant product, has the same number of trypto-
phans but four phenylalanines and seven tyrosine residues.
3.2. Circular dichroism
Near-UV CD spectra show that endogenous cruzipain has
more ¢ne structure than the recombinant enzyme (Fig. 2A).
The spectrum of recombinant cruzipain shows red shifts of
5 nm for the minimum (301 nm vs. 296 nm) and 9 nm for
the maximum (285 nm vs. 276 nm), and an almost two-fold
higher ellipticity at the maximum wavelength (Fig. 2A). Since
the 130 amino acids long C-terminal domain contains six
aromatic residues, four phenylalanine and two tyrosine resi-
dues and no tryptophan residues [7,8], most probably the
observed spectrum re£ects a cumulative e¡ect of these con-
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Fig. 1. Protein spectra of endogenous and recombinant cruzipain.
The spectrum of endogenous cruzipain is indicated with a continu-
ous line and recombinant cruzipain with a dashed line. The experi-
mental conditions were as described in Section 2.2.
Fig. 2. CD spectra of endogenous and recombinant cruzipain. The
experimental conditions for the near-UV (A) and far-UV (B) CD
spectra were as described in Section 2.3. The spectrum of endoge-
nous cruzipain is indicated with a continuous line and recombinant
cruzipain with a dashed line.
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tributions. The far-UV CD spectrum of endogenous and
recombinant cruzipain at pH 7.0 displays a maximum at
190 nm, a negative shoulder at 222 nm and a minimum at
208 nm (Fig. 2B). These pro¢les suggest that cruzipain be-
longs to the K+L protein class [19] where K-helix and L-strand
secondary structure segments are present in di¡erent domains
[20]. On the basis of far-UV CD spectra, at least three classes
of proteinases within the papain family have been identi¢ed,
type I (papain, caricain) [21], type II (chymopapain) [21], and
type III (bromelain) [22]. The catalytic domain of cruzipain,
calculated from the CD spectrum using CONTIN [18], con-
sists of 29% K-helices, 28% L-strand and 42% other elements.
Endogenous cruzipain has 19% K-helices, 35% L-strands and
46% of others. Mature endogenous cruzipain consist of both
the catalytic domain (215 amino acids) and the C-terminal
domain (130 amino acids) [7,8]. Therefore, based on the com-
position of the secondary structure elements calculated using
the CONTIN algorithm [18], and the number of amino acid
residues of each domain, we calculated that the C-terminal
domain consists of 46% L-structure (60 amino acids) and
54% random coil structure (70 amino acids).
3.3. Dependence of the rate of hydrolysis on substrate
concentration and pH
The kinetic parameters Vmax and Km were obtained at each
pH value by ¢tting the Michaelis-Menten or Haldane-Wenger
models to experimental data in the cases where substrate in-
hibition was pronounced [23]. Hydrolysis of Z-Phe-Arg-MCA
by endogenous and recombinant cruzipain at 25‡C in both
neutral and acidic pH, followed Michaelis-Menten kinetics
(Fig. 3A). However, signi¢cant substrate inhibition was ob-
served for both enzyme forms above neutral pH with the
e¡ect increasing with increasing pH (Fig. 3B). These results
show that substrate inhibition of cruzipain is a pH-dependent
process and that the C-terminal domain does not play an
essential role in this process. Previous studies on endogenous
cruzipain (Y strain) at pH 6.3 indicated a temperature de-
pendence of substrate inhibition [14].
3.4. pH dependence of kcat /Km
The pH-activity pro¢le of the second order rate constant
kcat/Km allows the determination of the pKa values, which
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Fig. 3. Dependence of the rate of hydrolysis of cruzipain on sub-
strate concentration at 25‡C. A: pH 7.0. B: pH 9.0. The experimen-
tal data were ¢tted at pH 7.0 according to the Michaelis-Menten
equation and at pH 9.0 according to the Haldane model [23]. The
kinetic parameters for endogenous (b) and recombinant cruzipain
(a), respectively, are listed below. The experimental conditions were
as described in Section 2.4.
Km, the Michaelis-Menten constant, Vmax, maximal velocity, and Ksi
the substrate inhibition constant. r3, recombinant.
Fig. 4. pH dependence of (kcat/Km)obs for substrate hydrolysis cata-
lyzed by cruzipain at 25‡C. The kinetic parameters for Z-Arg-Arg-
MCA (b) and Z-Phe-Arg-MCA (a) are listed below. The experi-
mental conditions were as described in Section 2.5.
The ionization constants (pK13pK3) and pH-independent rate con-
stants (k13k2) were obtained by non-linear regression analysis of
the experimental data.
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re£ect ionization of the amino acid residues of free enzyme
and is not a¡ected by the nature of the rate-limiting step or by
the non-productive substrate binding modes [24]. The pH de-
pendence of (kcat/Km)obs for the hydrolysis of Z-Arg-Arg-
MCA by cruzipain showed a bell-shaped pro¢le indicating
that at least two ionizing groups with pKa values 6.0 and
9.3 modulate the enzyme activity (Fig. 4). Hydrolysis of Z-
Phe-Arg-MCA by cruzipain was better interpreted by a ki-
netic model involving three ionizing groups [25] with pKa
values 3.4, 6.1 and 9.5 (Fig. 4). Recent studies on cruzipain
speci¢city with the substrate Abz-LVGGA-EDDnp (where
Abz- represents o-aminobenzoic acid and EDDnp is N-(2,4-
dinitrophenyl)ethylenediamine) similarly showed three ioniz-
ing groups in the enzyme molecule interacting with the sub-
strate with pKa values 3.59, 6.10 and 8.60 [26]. Lack of the
third ionizing group with the lowest pKa value (3.4) in the
case of Z-Arg-Arg-MCA hydrolysis (Fig. 4) could probably
be explained by low reactivity of cruzipain towards this sub-
strate at low pH, which is substantially lower than for Z-Phe-
Arg-MCA (s 40-fold, Fig. 4). These data are also in agree-
ment with previous ¢ndings that hydrophobic substrates ex-
hibit broader pH pro¢les when compared to substrates with
more hydrophilic side chains [14,27,28]. The three ionizing
groups cannot be identi¢ed with certainty, however, there
are several charged residues in the vicinity of the active site
which are the likely candidates: Asp60, Glu73, Asp158. Glu205,
which is located in the S2 position (Fig. 5), has been found to
be very important for catalysis [28,29]. Furthermore, Glu205
was found to be capable of adopting various conformations,
thus enabling cruzipain to bind substrates with both charged
and hydrophobic residues in the S2 position [28].
The essential structural features required for the mechanism
of action of cysteine proteinases are present in cruzipain (Fig.
5). These include a basic residue at position 17 for ion pair
formation and an additional protonic dissociation with a
pKaV4 to control the ion pair geometry, most probably
due to the Glu50 cluster [30]. A sequence alignment of pa-
pain-like enzymes shows that those residues are conserved
[31]. Nevertheless, site-directed mutagenesis will con¢rm the
speci¢c role of the proposed amino acid residues in the vicin-
ity of the catalytic site motif.
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Fig. 5. Top view of the active site region of cruzipain. The residues Cys25 and His159 (papain numbering) are drawn in bold line. Amino acid
residues involved in ion pair formation (Lys17), electrostatic cluster (Glu50) and charged residues in the active site surroundings are denoted.
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